Q2 2022 Holdings
Filed 2022-08-15 | 62 holdings | $31.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $11.6M | 688,989 | 36.5% |
| Centene Corp(CNC) | COM | 15135B101 | $10.9M | 129,011 | 34.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.3M | 35,900 | 23.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $1.2M | 40,000 | 3.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $408.0K | 692,357 | 1.3% |
| Bausch Health Companies Inc(BHC) | COM | 071734107 | $56.0K | 6,700 | 0.2% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $25.9K | 183,334 | 0.1% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $22.7K | 2,323,000 | 0.1% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $19.4K | 574,855 | 0.1% |
| Cigna Corp(CI) | COM | 125523100 | $14.0K | 53,034 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $12.7K | 525,438 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $10.4K | 61,953 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $9.4K | 39,959 | 0.0% |
| Bausch Health Companies Inc(BHC)Put | COM | 071734107 | $8.7K | 1,042,700 | 0.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $7.6K | 112,466 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $7.2K | 80,000 | 0.0% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $6.5K | 724,944 | 0.0% |
| Natus Medical Inc | COM | 639050103 | $6.3K | 190,956 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $6.2K | 119,061 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $5.5K | 105,000 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $5.3K | 488,965 | 0.0% |
| Biohaven Pharmaceutical Holding Company LTD(BHVN) | COM | G11196105 | $5.1K | 35,000 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $4.7K | 362,294 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $4.1K | 365,210 | 0.0% |
| Universal Health Services Inc(UHS) | CL B | 913903100 | $4.1K | 40,725 | 0.0% |
| Heska Corp(HSKAEUR) | COM RESTRC NEW | 42805E306 | $3.7K | 39,566 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $3.4K | 504,545 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $3.2K | 40,000 | 0.0% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $3.0K | 574,352 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.9K | 999,829 | 0.0% |
| Prometheus Biosciences IncPut | COM | 74349U108 | $2.9K | 101,600 | 0.0% |
| Eucrates Biomedical Acquisition Corp. | UNIT 10/23/2027 | G3141W114 | $2.5K | 248,674 | 0.0% |
| Health Sciences Acquisitions Corp 2 | ORD SHS | G4411D109 | $2.5K | 250,000 | 0.0% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.4K | 4,668,536 | 0.0% |
| Affimed NV | COM | N01045108 | $2.3K | 821,065 | 0.0% |
| Merus NV | COM | N5749R100 | $2.0K | 87,953 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.6K | 555,610 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $1.6K | 1,008,993 | 0.0% |
| Moleculin Biotech Inc | COM | 60855D200 | $1.5K | 1,036,853 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $1.5K | 735,908 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $1.3K | 856,428 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $1.2K | 58,556 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.1K | 152,159 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $969 | 315,564 | 0.0% |
| Neubase Therapeutics Inc | COM | 64132K102 | $952 | 906,445 | 0.0% |
| Isoplexis Corp | COM | 465005106 | $879 | 407,102 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $831 | 86,400 | 0.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $649 | 260,448 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $629 | 1,270,758 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $611 | 130,000 | 0.0% |